Seed Funding for Early Stage Research

The Gastric Cancer Foundation provides early funding for projects that show promise to facilitate the development of new treatments for gastric cancer.

Early-stage seed funding is extremely important because it enables researchers to generate sufficient preliminary data to submit compelling and competitive applications for large grants. It is often difficult for researchers to obtain this type of support. The Gastric Cancer Foundation has made early funding a special focus of its research strategy.


Exploiting KMT2 as a Predictive Marker and Therapeutic Target in Advanced Gastric Cancer

Dr. Heinz-Josef Lenz
USC Norris Comprehensive Cancer Center

$75,000 Granted in 2020

New Targets and Therapies for Chromosomal Instability Underlying Gastric Cancer

Dr. Adam Bass
Dana-Farber Cancer Institute

$75,000 Granted in 2020

Interperitoneal Project to Develop New Therapies for Peritoneal Caricinomatosis

Dr. Jaffer Ajani
MD Anderson Cancer Center

$75,000 Granted in 2019

Study to Test Effectiveness of Combination Drug Therapy to Target Gastric Cancers with FGFR2 Defect and Prevent Drug Resistance

Dr. Hanlee Ji
Stanford Genome Technology Center

$30,104 Granted in 2019

Studying the Gastric Cancer Microenvironment Using Single Cell Genomics

Dr. Hanlee Ji
Stanford Genome Technology Center

$38,518 Granted in 2019

Use of Next-Generation DNA Sequencing Technology to Perform Whole-Genome Level Analysis on large Cohort of Individuals with Gastric Cancer

Dr. James Ford
Stanford University Medical School

$550,000 Total Grants 2010-2015


Early-Stage Grants to Support Innovate New Research

Making Strategic Investments Toward a Cure

Together, we can find a cure for gastric cancer. Support our critical research studies and patient education initiatives and find your cause for hope.